Swiss-Scandinavian Bio-Business Seminar 2015

9th Swiss-Scandinavian Bio-Business Seminar

February 5, 2015 at SIX Stock Exchange building in Zurich.

 

REGISTRATION IS NOW CLOSED DUE TO MAXIMUM NUMBER OF PARTICIPANTS REACHED

 

The 9th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.

The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks.

  • The previous SSBBS 2014 gathered more than 120 participants.
  • A record of over 270 one-to-one meetings took place.
  • In nearly 50% of the matchmaking meetings, further contact was planned or a cooperation considered 

    Confirmed participants include:
  • MS Ventures  – Seventure Partner  – Bay City Capital  – Roche Venture Fund  – Novartis Venture Fund – Sunstone Capital –Creathor Venture – Novo Seeds – Aravis  – Endeavour Vision  – Redalpine  – Agire Invest  – Index Ventures – Industrifonden  – HBM Partners – Sarsia Seeds – NeoMed Management

  • Roche  – Novartis  – Pfizer – Takeda – MSD  – Roche Diagnostics  – Tillotts Pharma  – Vifor Pharma  –  Alexion Pharma

FOR MORE INFO go to "About SSBBS". 

 

B2B 2013   Audience 2013    Panel 2013  SSBBS2013 b2b


Organisers

Small
Small
Small
Small
Small
Small

In cooperation with

Small
Small
Small
Small
Small
Small

Supported by

Small
Small
Registration
closed since 26 Jan 2015
Organisers
Schedule
Registration 6 Sep – 26 Jan
Meeting Selection 15 Jan – 3 Feb
Event 5 Feb
Details
Language English
Venue Zurich
Bilateral Meetings
Participants 154
Meetings 364
Participants
Belgium 1
Denmark 11
Finland 14
France 6
Germany 1
Israel 1
Italy 1
Norway 10
Spain 1
Sweden 55
Switzerland 71
United Kingdom 1
United States 1
Total 174
Profile Views
Before Event13244
After Event 17362
Total30606